Finding the intracellular signaling pathways affected by mood disorder treatments.
about
Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis?Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatmentActivity-regulated genes as mediators of neural circuit plasticityNeuropeptides in depression: role of VGFThe neurobiology of retinoic acid in affective disordersWeight loss dynamics during combined fluoxetine and olanzapine treatmentDrug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric DisordersGlial abnormalities in mood disordersSignal transduction and genes-to-behaviors pathways in psychiatric diseasesEfficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study5-HT1A receptors, gene repression, and depression: guilt by associationDISC1: Structure, Function, and Therapeutic Potential for Major Mental IllnessChronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient miceBipolar disorder: candidate drug targets.Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.Antidepressants increase neural progenitor cells in the human hippocampus.The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitementReverse translational strategies for developing animal models of bipolar disorder.Stress-induced structural remodeling in hippocampus: prevention by lithium treatment.MAPK signaling determines anxiety in the juvenile mouse brain but depression-like behavior in adultsWhich clinical and experimental data link temporal lobe epilepsy with depression?Serotonin transporter binding of [123I]ADAM in bulimic women, their healthy twin sisters, and healthy women: a SPET studyDiverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain.Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.Age-modulated association between prefrontal NAA and the BDNF gene.Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex.Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3.Valproic acid protects neurons and promotes neuronal regeneration after brachial plexus avulsion.Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptorsThe role of BDNF as a mediator of neuroplasticity in bipolar disorder.Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand.Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging studyRegulation of neurite growth by inorganic pyrophosphatase 1 via JNK dephosphorylation.Psychiatry as a clinical neuroscience discipline.Recurrent catatonia treated with lithium and carbamazepine: a series of 2 casesNonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities.
P2860
Q24541513-3AE1AE8B-B59F-4334-A666-57D32606FA03Q24546379-E8196852-121C-47BD-A096-393DD2E740C4Q24633760-180A698F-FB4A-410F-9A75-100181F85DA7Q24647788-88414CF9-3A41-4F15-8E3B-D8CF6AC034E1Q24654189-E694CC65-BD92-4EF8-AD67-D81C803C0DE3Q24794172-9D587DD9-C2B8-49E8-9966-92D99D132F3EQ26748728-CFE95A94-5A8E-4B9B-AF34-CFEA3F7E9758Q26824029-13B019EA-F641-4F4E-AB8C-F54CD226037BQ28182063-0E83DEC3-4FE8-4338-B03E-81BAEF1BD074Q28248076-7F744C60-EC32-447A-A6C7-2E14E10AFDE0Q28292310-5E7C16E5-300D-4C00-984F-B3672B455C80Q28393891-F990BE9E-0D88-42F3-B644-D6E8EBB48E80Q28539744-9DE18E49-C266-4DAB-ACF5-B6CC846FD624Q28751133-B7DCEA3F-60B8-4AB8-8AFA-602816272BB2Q30467322-28A270D7-8766-42A9-A6BD-4891AB779B61Q30482397-2367B06B-C59B-4FB8-AA1E-A4C5D35550DBQ30484058-CA438108-A934-433D-8BF2-2B37D44FF0A2Q30489800-94928BB9-3A87-43B0-B91E-63E7DF269CF2Q30542879-DF50C0C3-0340-4E00-A79E-E4C68187C59DQ31057608-6913171A-0F35-471B-A517-BEC262C3944FQ31130656-17D65FEE-4E31-41A6-8C96-37C704157F23Q33285074-339F51F6-3221-4A6C-A29A-62197F79A5B8Q33316399-55B3EA43-6BAC-44D9-8D2A-1135E6AF36FCQ33569509-2CFD6BD7-354E-4105-8DB5-40205BF1C9B5Q33573983-13DF7EC2-5C46-4B74-8DEA-7C0D831068F6Q33630799-757CA873-A1A5-4CC2-B974-9D3DBCA208D2Q33872654-27FC4DB1-1528-4005-BB14-DF443C8E0F28Q33874356-BAB07D51-EBA9-441E-A10F-39B42C0B3DF5Q33874713-391A342F-D201-4338-8F74-FF9E6FA023A7Q34074409-8C108AF8-B580-4816-B0F0-5187543D4182Q34095059-9CC4A745-7BB1-4F5D-AE30-19A36CAA1DA7Q34116825-4EE37975-66A6-46F7-A6B1-8262DCFA2FFAQ34497541-D4FCC236-BB1F-4766-9F3E-9C2EAFAC3A50Q34621808-19F00FEC-4655-4D14-BF41-2ABE720BDE84Q34655500-3CF4BB42-D274-4794-B93F-54A2504D4539Q34661069-1D53504A-AD33-4E7E-B49F-D56933CAFC1BQ34692243-96345251-5822-4A6C-BF9D-DBFDE32A10F3Q35062086-A3D07521-E06A-48E8-B2AD-94608B7A38D2Q35062642-2876CBF1-D561-466E-94F3-5650C8FAA4E7Q35236721-4CB17D02-7EC6-45F0-905B-4D1C6922B828
P2860
Finding the intracellular signaling pathways affected by mood disorder treatments.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Finding the intracellular signaling pathways affected by mood disorder treatments.
@ast
Finding the intracellular signaling pathways affected by mood disorder treatments.
@en
type
label
Finding the intracellular signaling pathways affected by mood disorder treatments.
@ast
Finding the intracellular signaling pathways affected by mood disorder treatments.
@en
prefLabel
Finding the intracellular signaling pathways affected by mood disorder treatments.
@ast
Finding the intracellular signaling pathways affected by mood disorder treatments.
@en
P1433
P1476
Finding the intracellular signaling pathways affected by mood disorder treatments.
@en
P2093
Joseph T Coyle
Ronald S Duman
P304
P356
10.1016/S0896-6273(03)00195-8
P407
P577
2003-04-01T00:00:00Z